Publication | Open Access

Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)

Phase Ii TrialGastrointestinal OncologyMedicinePharmacologyColorectal CancerPathologyColorectal Cancer PatientsPharmacotherapyCancer TreatmentOncologyRadiation OncologyCancer ResearchAdvanced Disease